Trial Profile
Efficacy of prasugrel given immediately after percutaneous coronary intervention in acute myocardial infarction
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Sep 2015
Price :
$35
*
At a glance
- Drugs Prasugrel (Primary)
- Indications Myocardial infarction
- Focus Therapeutic Use
- 14 Sep 2015 New trial record